• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞(DC)成熟的时间因素:短期激活 DC 可显著提高 1 型细胞因子的产生和 T 细胞应答。

Factor of time in dendritic cell (DC) maturation: short-term activation of DCs significantly improves type 1 cytokine production and T cell responses.

机构信息

Slovenian Institute for Transfusion Medicine, Šlajmerjeva 6, Ljubljana, 1000, Slovenia.

Faculty of Medicine, University of Ljubljana, Korytkova ulica 2, Ljubljana, 1000, Slovenia.

出版信息

J Transl Med. 2024 Jun 6;22(1):541. doi: 10.1186/s12967-024-05368-4.

DOI:10.1186/s12967-024-05368-4
PMID:38845003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11155046/
Abstract

Dendritic cells (DCs) have been intensively studied in correlation to tumor immunology and for the development DC-based cancer vaccines. Here, we present the significance of the temporal aspect of DC maturation for the most essential subsequent timepoint, namely at interaction with responding T cells or after CD40-Ligand restimulation. Mostly, DC maturation is still being achieved by activation processes which lasts 24 h to 48 h. We hypothesized this amount of time is excessive from a biological standpoint and could be the underlying cause for functional exhaustion. Indeed, shorter maturation periods resulted in extensive capacity of monocyte-derived DCs to produce inflammatory cytokines after re-stimulation with CD40-Ligand. This effect was most evident for the primary type 1 polarizing cytokine, IL-12p70. This capacity reached peak at 6 h and dropped sharply with longer exposure to initial maturation stimuli (up to 48 h). The 6 h maturation protocol reflected superiority in subsequent functionality tests. Namely, DCs displayed twice the allostimulatory capacity of 24 h- and 48 h-matured DCs. Similarly, type 1 T cell response measured by IFN-γ production was 3-fold higher when CD4 T cells had been stimulated with shortly matured DC and over 8-fold greater in case of CD8 T cells, compared to longer matured DCs. The extent of melanoma-specific CD8 cytotoxic T cell induction was also greater in case of 6 h DC maturation. The major limitation of the study is that it lacks in vivo evidence, which we aim to examine in the future. Our findings show an unexpectedly significant impact of temporal exposure to activation signals for subsequent DC functionality, which we believe can be readily integrated into existing knowledge on in vitro/ex vivo DC manipulation for various uses. We also believe this has important implications for DC vaccine design for future clinical trials.

摘要

树突状细胞 (DC) 在肿瘤免疫学研究和基于 DC 的癌症疫苗开发方面受到了广泛关注。在这里,我们介绍了 DC 成熟的时间方面对于最重要的后续时间点(即与反应性 T 细胞相互作用或在 CD40L 刺激后)的重要性。大多数情况下,DC 的成熟仍然是通过持续 24 至 48 小时的激活过程来实现的。我们假设从生物学角度来看,这段时间过长,可能是功能衰竭的根本原因。事实上,较短的成熟时间导致单核细胞来源的 DC 在再次用 CD40L 刺激后产生大量炎性细胞因子。对于主要的 1 型极化细胞因子 IL-12p70,这种效应最为明显。这种能力在 6 小时达到峰值,并随着初始成熟刺激时间的延长而急剧下降(最长可达 48 小时)。6 小时的成熟方案在后续功能测试中表现出优越性。即,6 小时成熟的 DC 的同种刺激能力是 24 小时和 48 小时成熟的 DC 的两倍。同样,当 CD4 T 细胞用短暂成熟的 DC 刺激时,产生 IFN-γ 的 1 型 T 细胞反应是用 24 小时和 48 小时成熟的 DC 刺激时的两倍,而在 CD8 T 细胞中,这种反应是用 24 小时和 48 小时成熟的 DC 刺激时的 8 倍以上。在 6 小时 DC 成熟的情况下,黑素瘤特异性 CD8 细胞毒性 T 细胞的诱导程度也更高。该研究的主要局限性在于缺乏体内证据,我们旨在未来进行检验。我们的研究结果表明,DC 随后的功能与暴露于激活信号的时间长短之间存在出乎意料的显著影响,我们相信这可以很容易地整合到现有的关于各种用途的体外/离体 DC 操作的知识中。我们还认为,这对未来临床试验中 DC 疫苗的设计具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/335d05d4f0fe/12967_2024_5368_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/77bd326408b9/12967_2024_5368_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/49e572a1b450/12967_2024_5368_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/cc36f6c7046a/12967_2024_5368_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/26e5dc24f14f/12967_2024_5368_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/c6830e15cf9a/12967_2024_5368_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/bfcecc84c824/12967_2024_5368_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/335d05d4f0fe/12967_2024_5368_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/77bd326408b9/12967_2024_5368_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/49e572a1b450/12967_2024_5368_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/cc36f6c7046a/12967_2024_5368_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/26e5dc24f14f/12967_2024_5368_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/c6830e15cf9a/12967_2024_5368_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/bfcecc84c824/12967_2024_5368_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3dc/11155046/335d05d4f0fe/12967_2024_5368_Fig7_HTML.jpg

相似文献

1
Factor of time in dendritic cell (DC) maturation: short-term activation of DCs significantly improves type 1 cytokine production and T cell responses.树突状细胞(DC)成熟的时间因素:短期激活 DC 可显著提高 1 型细胞因子的产生和 T 细胞应答。
J Transl Med. 2024 Jun 6;22(1):541. doi: 10.1186/s12967-024-05368-4.
2
Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.成熟刺激的顺序递送可增加人树突状细胞白细胞介素-12的产生,并增强肿瘤抗原特异性免疫原性。
J Surg Res. 2004 Jan;116(1):24-31. doi: 10.1016/j.jss.2003.09.003.
3
Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.通过腺病毒介导的hCD40L基因与γ干扰素共转染,生成同时分泌白细胞介素-12并具有迁移能力的人树突状细胞。
J Immunother. 2009 Jun;32(5):524-38. doi: 10.1097/CJI.0b013e3181a28422.
4
Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.联合 TLR-3/TLR-8 信号在 α-型 1 细胞因子存在的情况下代表了一种新型的、有效的树突状细胞 1 型、抗肿瘤成熟方案。
Cells. 2022 Feb 28;11(5):835. doi: 10.3390/cells11050835.
5
Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.临床级树突状细胞的Th1极化能力由免疫核糖核酸触发,但受前列腺素E2损害:成熟混合物的重要性。
J Immunother. 2005 Sep-Oct;28(5):480-7. doi: 10.1097/01.cji.0000171290.78495.66.
6
Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.通过电穿孔将编码 CD40 配体、组成性激活 TLR4 和 CD70 的 mRNA 转染入单核细胞来源的树突状细胞以调节调节性 T 细胞的功能。
J Immunol. 2013 Aug 15;191(4):1976-83. doi: 10.4049/jimmunol.1201008. Epub 2013 Jul 10.
7
Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.树突状细胞介导的黑色素瘤特异性细胞毒性 T 细胞诱导过程中自然杀伤细胞的辅助活性。
J Immunother. 2011 Apr;34(3):270-8. doi: 10.1097/CJI.0b013e31820b370b.
8
Dendritic cells cultured in anti-CD40 antibody-immobilized plates elicit a highly efficient peptide-specific T-cell response.在固定有抗CD40抗体的平板中培养的树突状细胞引发高效的肽特异性T细胞反应。
J Immunother. 2002 Mar-Apr;25(2):176-84. doi: 10.1097/00002371-200203000-00005.
9
Dendritic cell gene therapy.树突状细胞基因治疗。
Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. doi: 10.1016/s1055-3207(02)00027-3.
10
Late dendritic cells are still able to evoke a potent alloreactive CTL response.晚期树突状细胞仍能够引发强烈的同种异体反应性CTL应答。
Immunobiology. 2008;213(1):51-64. doi: 10.1016/j.imbio.2007.06.005. Epub 2007 Aug 6.

引用本文的文献

1
PD-L1 siRNA incorporation into a cationic liposomal tumor mRNA vaccine enhances cytotoxic T cell activation and prevents immune evasion.将程序性死亡配体1(PD-L1)小干扰RNA(siRNA)整合到阳离子脂质体肿瘤信使核糖核酸(mRNA)疫苗中可增强细胞毒性T细胞活化并防止免疫逃逸。
Mater Today Bio. 2025 Feb 22;31:101603. doi: 10.1016/j.mtbio.2025.101603. eCollection 2025 Apr.

本文引用的文献

1
Vaccine adjuvants: mechanisms and platforms.疫苗佐剂:作用机制与平台。
Signal Transduct Target Ther. 2023 Jul 19;8(1):283. doi: 10.1038/s41392-023-01557-7.
2
Human dendritic cells in cancer.癌症中的人类树突状细胞。
Sci Immunol. 2022 Apr;7(70):eabm9409. doi: 10.1126/sciimmunol.abm9409. Epub 2022 Apr 1.
3
Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.联合 TLR-3/TLR-8 信号在 α-型 1 细胞因子存在的情况下代表了一种新型的、有效的树突状细胞 1 型、抗肿瘤成熟方案。
Cells. 2022 Feb 28;11(5):835. doi: 10.3390/cells11050835.
4
Exhausted mature dendritic cells exhibit a slower and less persistent random motility but retain chemotaxis against CCL19.疲惫的成熟树突状细胞表现出较慢和较不持久的随机运动,但仍能趋化 CCL19。
Lab Chip. 2022 Jan 18;22(2):377-386. doi: 10.1039/d1lc00876e.
5
Dendritic Cells Revisited.树突状细胞再探。
Annu Rev Immunol. 2021 Apr 26;39:131-166. doi: 10.1146/annurev-immunol-061020-053707. Epub 2021 Jan 22.
6
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade.树突状细胞上的 PD-L1 可减弱 T 细胞的激活,并调节对免疫检查点阻断的反应。
Nat Commun. 2020 Sep 24;11(1):4835. doi: 10.1038/s41467-020-18570-x.
7
Antitumour dendritic cell vaccination in a priming and boosting approach.树突状细胞瘤苗接种在初步免疫和加强免疫中的应用。
Nat Rev Drug Discov. 2020 Sep;19(9):635-652. doi: 10.1038/s41573-020-0074-8. Epub 2020 Aug 6.
8
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression.JAK-STAT信号传导:免疫调节与癌症进展的双刃剑
Cancers (Basel). 2019 Dec 12;11(12):2002. doi: 10.3390/cancers11122002.
9
Dendritic Cells Generated in the Presence of Platelet Lysate Have a Reduced Type 1 Polarization Capacity.在血小板裂解物存在的情况下生成的树突状细胞的 1 型极化能力降低。
Immunol Invest. 2020 Apr;49(3):215-231. doi: 10.1080/08820139.2019.1624768. Epub 2019 Jun 7.
10
An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination.一种加速的、临床级别的方案,用于生成高产量的负载 I 型极化信使 RNA 的树突状细胞,用于癌症疫苗接种。
Cytotherapy. 2018 Sep;20(9):1164-1181. doi: 10.1016/j.jcyt.2018.06.006. Epub 2018 Aug 16.